In-process R&D: To capitalize or expense?

Zhen Deng, Baruch Lev*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

The FASB recently proposed the capitalization of acquired in-process R&D costs to replace the current practice of expensing this item. This proposal will likely be strongly opposed by corporate executives. We examine whether in-process R&D is an asset worthy of capitalization or an expense, and, if it is an asset, how reliable is its estimate. We find a significant association between the values of in-process R&D and acquiring firms' cash flows during the 3 years subsequent to acquisition, thereby supporting the FASB's proposal to recognize in-process R&D as an asset. Preliminary tests are positive for the reliability/objectivity of in-process R&D estimates.

Original languageEnglish
Pages (from-to)18-32
Number of pages15
JournalJournal of Engineering and Technology Management - JET-M
Volume23
Issue number1-2 SPEC. ISS.
DOIs
StatePublished - 2006
Externally publishedYes

Keywords

  • Capitalization
  • Cashflows
  • Intangibles
  • R&D

Fingerprint

Dive into the research topics of 'In-process R&D: To capitalize or expense?'. Together they form a unique fingerprint.

Cite this